TIGIT and malignant colon neoplasm: demonstrated that TIGIT is associated with NK cell exhaustion in tumor-bearing mice and patients with colon cancer, and blockade of TIGIT prevents NK cell exhaustion and promotes NK cell-dependent tumor immunity in several tumor-bearing mouse models (29).